Pancreatic Cancer Research

ResearcherAnhui Medical UniversityNo recent work listed

Liwei Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-1402-0656; OpenAlex author ID A5102396881. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2013: 5 papers · 2014: 1 paper

Papers 6

  1. [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. Last author PMID 25331466↗
  2. Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-013-1422-4↗
  3. Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12032-013-0583-y↗
  4. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycopr… Co-author DOI 10.1016/j.pan.2013.03.010↗
  5. Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer. Last author DOI 10.3892/ol.2013.1326↗
  6. [Analysis of pancreatic cancer peripheral blood by comparative proteomics]. Last author PMID 23578431↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ren-bao Yang · 6 shared papers, 2013–2014 · strength 0.23
  2. Jiong Chen · 6 shared papers, 2013–2014 · strength 0.23
  3. Longjiang Chen · 6 shared papers, 2013–2014 · strength 0.23
  4. Yue Zhao · 3 shared papers, 2013–2014 · strength 0.12
  5. Yue Zhao · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.